A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer

BackgroundSkin-related adverse events (AEs) induced by apalutamide occur frequently in Japanese patients with prostate cancer. However, biomarkers for predicting these skin-related AEs have not yet been identified. Therefore, this study investigated whether the proportion of eosinophils could serve...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Yoshihiko Tasaki, Taku Naiki, Yoshihisa Mimura, Yosuke Sugiyama, Misato Tomita, Toshiharu Morikawa, Takashi Nagai, Rei Unno, Toshiki Etani, Shuzo Hamamoto, Yukihiro Umemoto, Takahiro Yasui, Yoko Furukawa-Hibi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-10-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1681734/full